Literature DB >> 25733681

RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology.

Hetian Lei1, Cynthia X Qian2, Jinghu Lei3, Luis J Haddock2, Shizuo Mukai2, Andrius Kazlauskas4.   

Abstract

Platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) make profound contributions to both physiology and pathology. While it is widely believed that direct (PDGF-mediated) activation is the primary mode of activating PDGFRs, the discovery that they can also be activated indirectly begs the question of the relevance of the indirect mode of activating PDGFRs. In the context of a blinding eye disease, indirect activation of PDGFRα results in persistent signaling, which suppresses the level of p53 and thereby promotes viability of cells that drive pathogenesis. Under the same conditions, PDGFRβ fails to undergo indirect activation. In this paper, we report that RasGAP (GTPase-activating protein of Ras) prevented indirect activation of PDGFRβ. RasGAP, which associates with PDGFRβ but not PDGFRα, reduced the level of mitochondrion-derived reactive oxygen species, which are required for enduring activation of PDGFRs. Furthermore, preventing PDGFRβ from associating with RasGAP allowed it to signal enduringly and drive pathogenesis of a blinding eye disease. These results indicate a previously unappreciated role of RasGAP in antagonizing indirect activation of PDGFRβ, define the underlying mechanism, and raise the possibility that PDGFRβ-mediated diseases involve indirect activation of PDGFRβ.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25733681      PMCID: PMC4405646          DOI: 10.1128/MCB.01248-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Phosphospecific antibodies reveal temporal regulation of platelet-derived growth factor beta receptor signaling.

Authors:  A Bernard; A Kazlauskas
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

2.  Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression.

Authors:  S Rosenkranz; Y Ikuno; F L Leong; R A Klinghoffer; S Miyake; H Band; A Kazlauskas
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

3.  The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions.

Authors:  R A Klinghoffer; P F Mueting-Nelsen; A Faerman; M Shani; P Soriano
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  TGFbeta1-dependent contraction of fibroblasts is mediated by the PDGFalpha receptor.

Authors:  Yasushi Ikuno; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

Review 5.  Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?

Authors:  Steven Pennock; Luis J Haddock; Dean Eliott; Shizuo Mukai; Andrius Kazlauskas
Journal:  Prog Retin Eye Res       Date:  2014-01-09       Impact factor: 21.198

6.  A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy.

Authors:  Steven Pennock; Marc-Andre Rheaume; Shizuo Mukai; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2011-10-28       Impact factor: 4.307

7.  Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells.

Authors:  Hetian Lei; Marc-André Rhéaume; Gisela Velez; Shizuo Mukai; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-24       Impact factor: 4.799

Review 8.  Regulation of protein tyrosine phosphatases by reversible oxidation.

Authors:  Arne Ostman; Jeroen Frijhoff; Asa Sandin; Frank-D Böhmer
Journal:  J Biochem       Date:  2011-08-19       Impact factor: 3.387

9.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

10.  A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α.

Authors:  Hetian Lei; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

View more
  12 in total

1.  Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.

Authors:  Haote Han; Na Chen; Xionggao Huang; Bing Liu; Jingkui Tian; Hetian Lei
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

2.  The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells.

Authors:  Yajian Duan; Gaoen Ma; Xionggao Huang; Patricia A D'Amore; Feng Zhang; Hetian Lei
Journal:  J Biol Chem       Date:  2016-05-31       Impact factor: 5.157

3.  Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia.

Authors:  Steven Pennock; Leo A Kim; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

4.  PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.

Authors:  Wenyi Wu; Guohong Zhou; Haote Han; Xionggao Huang; Heng Jiang; Shizuo Mukai; Andrius Kazlauskas; Jing Cui; Joanne Aiko Matsubara; Bart Vanhaesebroeck; Xiaobo Xia; Jiantao Wang; Hetian Lei
Journal:  Diabetes       Date:  2020-01-08       Impact factor: 9.461

5.  Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.

Authors:  Gaoen Ma; Yajian Duan; Xionggao Huang; Cynthia X Qian; Yewlin Chee; Shizuo Mukai; Jing Cui; Arif Samad; Joanne Aiko Matsubara; Andrius Kazlauskas; Patricia A D'Amore; Shuyan Gu; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

6.  AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro.

Authors:  Wenyi Wu; Yajian Duan; Gaoen Ma; Guohong Zhou; Cindy Park-Windhol; Patricia A D'Amore; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-12-01       Impact factor: 4.799

7.  Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.

Authors:  Guohong Zhou; Yajiang Duan; Gaoen Ma; Wenyi Wu; Zhengping Hu; Na Chen; Yewlin Chee; Jing Cui; Arif Samad; Joanne A Matsubara; Shizuo Mukai; Patricia A D'Amore; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

8.  Genome editing abrogates angiogenesis in vivo.

Authors:  Xionggao Huang; Guohong Zhou; Wenyi Wu; Yajian Duan; Gaoen Ma; Jingyuan Song; Ru Xiao; Luk Vandenberghe; Feng Zhang; Patricia A D'Amore; Hetian Lei
Journal:  Nat Commun       Date:  2017-07-24       Impact factor: 14.919

9.  Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation.

Authors:  Xionggao Huang; Guohong Zhou; Wenyi Wu; Gaoen Ma; Patricia A D'Amore; Shizuo Mukai; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-02-01       Impact factor: 4.799

10.  PDGFRα Is a Key Regulator of T1 and T3's Differential Effect on SMA Expression in Human Corneal Fibroblasts.

Authors:  Sriniwas Sriram; Jennifer A Tran; Xiaoqing Guo; Audrey E K Hutcheon; Hetian Lei; Andrius Kazlauskas; James D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-02-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.